News and Trends 12 May 2023
Cell and gene therapy company NewBiologix exits stealth with $50M
…leap forward. Our approach will significantly impact the cost of goods sold (COGs), making gene therapy more viable for rare diseases.” NewBiologix is leveraging next-generation sequencing (NGS)-based genome characterization to…